<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001965743</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Common Stock, Par Value $0.001 Per Share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>02/21/2025</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001624326</issuerCik>
        <issuerName>PAVmed Inc.</issuerName>
        <issuerCusip>70387R403</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>360 MADISON AVENUE</com:street1>
          <com:street2>25TH FLOOR</com:street2>
          <com:city>NEW YORK</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10017</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>Tasso Partners, LLC</reportingPersonName>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>2574350.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>2574350.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>2574350.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <classPercent>18.9</classPercent>
      <typeOfReportingPerson>OO</typeOfReportingPerson>
      <comments>The number of shares beneficially owned excludes 53,974 shares of common stock issuable upon the exercise of warrants that are not currently exercisable and will not become exercisable within 60 days.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>Dana Carrera</reportingPersonName>
      <citizenshipOrOrganization>X1</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>2574350.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>2574350.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>2574350.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <classPercent>18.9</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
      <comments>The number of shares beneficially owned excludes 53,974 shares of common stock issuable upon the exercise of warrants that are not currently exercisable and will not become exercisable within 60 days. Dana Carrera controls Tasso Capital, LLC, which in turn controls Tasso Partners, LLC.</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>PAVmed Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>360 MADISON AVENUE, 25TH FLOOR, NEW YORK, NEW YORK, 10017.</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>This Schedule 13G is filed by Tasso Partners, LLC ("Tasso Partners") and Dana Carrera ("Ms. Carrera," and together with Tasso Partners, the "Reporting Persons"). Ms. Carrera controls Tasso Capital, LLC, which in turn controls Tasso Partners. The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed as Exhibit 99.1 to this Schedule 13G, pursuant to which such Reporting Persons have agreed to file this Schedule 13G and all subsequent amendments to the Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k) of the Act. Any disclosures herein with respect to persons other than the Reporting Persons is made on information and belief after making inquiry to the appropriate party. The filing of this Schedule 13G should not be construed in and of itself as an admission by any Reporting Person as to beneficial ownership of the shares of Common Stock reported herein.</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>The principal business address of each of the Reporting Persons is: P.O. Box 503, Rumson, NJ 07760.</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Tasso Partners is a limited liability company formed under the laws of Delaware. Ms. Carrera is a citizen of the United States.</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>Tasso Partners beneficially owns 2,574,350 shares of common stock. The number of shares beneficially owned by Tasso Partners excludes 53,974 shares of common stock issuable upon the exercise of warrants held by the Reporting Person that are not currently exercisable and will not become exercisable within 60 days.  Ms. Carrera may be deemed to beneficially own the shares of common stock held by Tasso Partners, because Ms. Carrera indirectly controls Tasso Partners. </amountBeneficiallyOwned>
        <classPercent>Tasso Partners and Ms. Carrera beneficially own 18.9% of the outstanding shares of common stock. The percentage of beneficial ownership is calculated based on 11,068,566 shares of common stock outstanding as of November 25, 2024, as set forth in the Company's registration statement on Form S-3 filed on December 20, 2024.</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>Tasso Partners: 2,574,350
Ms. Carrera: 2,574,350</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>Tass Partners: 0
Ms. Carrera:0</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>Tasso Partners: 2,574,350
Ms. Carrera: 2,574,350</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>Tass Partners: 0
Ms. Carrera:0</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
        <classOwnership5PercentOrLess>N</classOwnership5PercentOrLess>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under &amp;#167; 240.14a-11.

</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Tasso Partners, LLC</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Dana Carrera</signature>
        <title>Dana Carrera, Manager of Tasso Capital, LLC, which controls Tasso Partners, LLC</title>
        <date>02/28/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Dana Carrera</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Dana Carrera</signature>
        <title>Dana Carrera</title>
        <date>02/28/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>

</edgarSubmission>
